{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:12:20Z","timestamp":1778854340792,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s40618-020-01274-w","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T04:06:08Z","timestamp":1588219568000},"page":"105-110","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Circulating levels of fetuin-A are associated with moderate\u2013severe hepatic steatosis in young adults"],"prefix":"10.1007","volume":"44","author":[{"given":"T.","family":"Filardi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Panimolle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Tiberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Crescioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Pallotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8156-9543","authenticated-orcid":false,"given":"S.","family":"Morano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,30]]},"reference":[{"issue":"1","key":"1274_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M (2016) Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64(1):73\u201384. https:\/\/doi.org\/10.1002\/hep.28431","journal-title":"Hepatology"},{"issue":"3","key":"1274_CR2","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.cgh.2014.08.037","volume":"13","author":"ER Kallwitz","year":"2015","unstructured":"Kallwitz ER, Daviglus ML, Allison MA, Emory KT, Zhao L, Kuniholm MH, Chen J, Gouskova N, Pirzada A, Talavera GA, Youngblood ME, Cotler SJ (2015) Prevalence of suspected nonalcoholic fatty liver disease in Hispanic\/Latino individuals differs by heritage. Clin Gastroenterol Hepatol 13(3):569\u2013576. https:\/\/doi.org\/10.1016\/j.cgh.2014.08.037","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"1274_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hep.29466","volume":"67","author":"C Estes","year":"2018","unstructured":"Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ (2018) Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology 67(1):123\u2013133. https:\/\/doi.org\/10.1002\/hep.29466","journal-title":"Hepatology"},{"issue":"5","key":"1274_CR4","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.2337\/dc06-2247","volume":"30","author":"G Targher","year":"2007","unstructured":"Targher G, Bertolini L, Padovani R, Rodella S, Tessari R, Zenari L, Day C, Arcaro G (2007) Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 30(5):1212\u20131218. https:\/\/doi.org\/10.2337\/dc06-2247","journal-title":"Diabetes Care"},{"issue":"3","key":"1274_CR5","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/hep.25772","volume":"56","author":"R Loomba","year":"2012","unstructured":"Loomba R, Abraham M, Unalp A, Wilson L, Lavine J, Doo E, Bass NM, Nonalcoholic Steatohepatitis Clinical Research N (2012) Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis. Hepatology 56(3):943\u2013951. https:\/\/doi.org\/10.1002\/hep.25772","journal-title":"Hepatology"},{"issue":"1","key":"1274_CR6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","volume":"14","author":"H Tilg","year":"2017","unstructured":"Tilg H, Moschen AR, Roden M (2017) NAFLD and diabetes mellitus. Nat Rev Gastroenterol Hepatol 14(1):32\u201342. https:\/\/doi.org\/10.1038\/nrgastro.2016.147","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1274_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev-physiol-021115-105331","volume":"78","author":"JT Haas","year":"2016","unstructured":"Haas JT, Francque S, Staels B (2016) Pathophysiology and mechanisms of nonalcoholic fatty liver disease. Annu Rev Physiol 78:181\u2013205. https:\/\/doi.org\/10.1146\/annurev-physiol-021115-105331","journal-title":"Annu Rev Physiol"},{"issue":"3","key":"1274_CR8","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/hep.26717","volume":"59","author":"MJ Armstrong","year":"2014","unstructured":"Armstrong MJ, Adams LA, Canbay A, Syn WK (2014) Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology 59(3):1174\u20131197. https:\/\/doi.org\/10.1002\/hep.26717","journal-title":"Hepatology"},{"key":"1274_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8122033","author":"L Bourebaba","year":"2019","unstructured":"Bourebaba L, Marycz K (2019) Pathophysiological implication of fetuin-A glycoprotein in the development of metabolic disorders: a concise review. J Clin Med. https:\/\/doi.org\/10.3390\/jcm8122033","journal-title":"J Clin Med"},{"issue":"10","key":"1274_CR10","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.2337\/db08-0538","volume":"57","author":"N Stefan","year":"2008","unstructured":"Stefan N, Fritsche A, Weikert C, Boeing H, Joost HG, Haring HU, Schulze MB (2008) Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes 57(10):2762\u20132767. https:\/\/doi.org\/10.2337\/db08-0538","journal-title":"Diabetes"},{"issue":"11","key":"1274_CR11","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1210\/mend.7.11.7906861","volume":"7","author":"PR Srinivas","year":"1993","unstructured":"Srinivas PR, Wagner AS, Reddy LV, Deutsch DD, Leon MA, Goustin AS, Grunberger G (1993) Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level. Mol Endocrinol 7(11):1445\u20131455. https:\/\/doi.org\/10.1210\/mend.7.11.7906861","journal-title":"Mol Endocrinol"},{"issue":"4","key":"1274_CR12","doi-asserted-by":"publisher","first-page":"853","DOI":"10.2337\/diacare.29.04.06.dc05-1938","volume":"29","author":"N Stefan","year":"2006","unstructured":"Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Krober SM, Machicao F, Fritsche A, Haring HU (2006) Alpha2-Heremans-Schmid glycoprotein\/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 29(4):853\u2013857. https:\/\/doi.org\/10.2337\/diacare.29.04.06.dc05-1938","journal-title":"Diabetes Care"},{"issue":"2","key":"1274_CR13","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s12020-016-1008-4","volume":"57","author":"N Pallotta","year":"2017","unstructured":"Pallotta N, Filardi T, Carnovale A, Nieddu L, Mariani P, Vincoli G, Lenzi A, Morano S (2017) Two-hour postload glycemia is associated to an increased risk of NAFLD in healthy subjects with family history of type 2 diabetes: a case control study. Endocrine 57(2):352\u2013355. https:\/\/doi.org\/10.1007\/s12020-016-1008-4","journal-title":"Endocrine"},{"issue":"4","key":"1274_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","volume":"145","author":"AS Levey","year":"2006","unstructured":"Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F, Chronic Kidney Disease Epidemiology C (2006) Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145(4):247\u2013254. https:\/\/doi.org\/10.7326\/0003-4819-145-4-200608150-00004","journal-title":"Ann Intern Med"},{"key":"1274_CR15","unstructured":"Oxford University HOMA2 Calculator. https:\/\/www.dtu.ox.ac.uk\/homacalculator\/. Accessed 9 Mar 2020"},{"key":"1274_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2147\/DMSO.S80364","volume":"8","author":"CR Lesmana","year":"2015","unstructured":"Lesmana CR, Pakasi LS, Inggriani S, Aidawati ML, Lesmana LA (2015) Development of non-alcoholic fatty liver disease scoring system among adult medical check-up patients: a large cross-sectional and prospective validation study. Diabetes Metab Syndr Obes 8:213\u2013218. https:\/\/doi.org\/10.2147\/DMSO.S80364","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"1274_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/clpt.1981.18","volume":"29","author":"MS Kramer","year":"1981","unstructured":"Kramer MS, Feinstein AR (1981) Clinical biostatistics. LIV. The biostatistics of concordance. Clin Pharmacol Ther 29(1):111\u2013123. https:\/\/doi.org\/10.1038\/clpt.1981.18","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"1274_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jhep.2019.08.032","volume":"72","author":"G Berardi","year":"2020","unstructured":"Berardi G, Morise Z, Sposito C, Igarashi K, Panetta V, Simonelli I, Kim S, Goh BKP, Kubo S, Tanaka S, Takeda Y, Ettorre GM, Wilson GC, Cimino M, Chan CY, Torzilli G, Cheung TT, Kaneko H, Mazzaferro V, Geller DA, Han HS, Kanazawa A, Wakabayashi G, Troisi RI (2020) Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis. J Hepatol 72(1):75\u201384. https:\/\/doi.org\/10.1016\/j.jhep.2019.08.032","journal-title":"J Hepatol"},{"key":"1274_CR19","doi-asserted-by":"publisher","first-page":"7918714","DOI":"10.1155\/2018\/7918714","volume":"2018","author":"HS Chung","year":"2018","unstructured":"Chung HS, Lee HJ, Hwang SY, Choi JH, Yoo HJ, Seo JA, Kim SG, Kim NH, Choi DS, Baik SH, Choi KM (2018) Relationship of circulating fetuin-A Levels with body size and metabolic phenotypes. Int J Endocrinol 2018:7918714. https:\/\/doi.org\/10.1155\/2018\/7918714","journal-title":"Int J Endocrinol"},{"issue":"63","key":"1274_CR20","doi-asserted-by":"publisher","first-page":"107149","DOI":"10.18632\/oncotarget.22361","volume":"8","author":"Z Cui","year":"2017","unstructured":"Cui Z, Xuan R, Yang Y (2017) Serum fetuin A level is associated with nonalcoholic fatty liver disease in Chinese population. Oncotarget 8(63):107149\u2013107156. https:\/\/doi.org\/10.18632\/oncotarget.22361","journal-title":"Oncotarget"},{"issue":"3","key":"1274_CR21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4103\/1319-3767.157556","volume":"21","author":"G Celebi","year":"2015","unstructured":"Celebi G, Genc H, Gurel H, Sertoglu E, Kara M, Tapan S, Acikel C, Karslioglu Y, Ercin CN, Dogru T (2015) The relationship of circulating fetuin-a with liver histology and biomarkers of systemic inflammation in nondiabetic subjects with nonalcoholic fatty liver disease. Saudi J Gastroenterol 21(3):139\u2013145. https:\/\/doi.org\/10.4103\/1319-3767.157556","journal-title":"Saudi J Gastroenterol"},{"issue":"4","key":"1274_CR22","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/j.1365-2265.2011.04070.x","volume":"75","author":"HY Ou","year":"2011","unstructured":"Ou HY, Yang YC, Wu HT, Wu JS, Lu FH, Chang CJ (2011) Serum fetuin-A concentrations are elevated in subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes. Clin Endocrinol (Oxf) 75(4):450\u2013455. https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04070.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"14","key":"1274_CR23","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1161\/CIRCULATIONAHA.105.588723","volume":"113","author":"JH Ix","year":"2006","unstructured":"Ix JH, Shlipak MG, Brandenburg VM, Ali S, Ketteler M, Whooley MA (2006) Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation 113(14):1760\u20131767. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.588723","journal-title":"Circulation"},{"issue":"7","key":"1274_CR24","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.jprot.2011.03.010","volume":"74","author":"A Roca-Rivada","year":"2011","unstructured":"Roca-Rivada A, Alonso J, Al-Massadi O, Castelao C, Peinado JR, Seoane LM, Casanueva FF, Pardo M (2011) Secretome analysis of rat adipose tissues shows location-specific roles for each depot type. J Proteomics 74(7):1068\u20131079. https:\/\/doi.org\/10.1016\/j.jprot.2011.03.010","journal-title":"J Proteomics"},{"issue":"2","key":"1274_CR25","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s12020-016-1132-1","volume":"55","author":"D Perez-Sotelo","year":"2017","unstructured":"Perez-Sotelo D, Roca-Rivada A, Larrosa-Garcia M, Castelao C, Baamonde I, Baltar J, Crujeiras AB, Seoane LM, Casanueva FF, Pardo M (2017) Visceral and subcutaneous adipose tissue express and secrete functional alpha2hsglycoprotein (fetuin a) especially in obesity. Endocrine 55(2):435\u2013446. https:\/\/doi.org\/10.1007\/s12020-016-1132-1","journal-title":"Endocrine"},{"issue":"1","key":"1274_CR26","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.bbadis.2016.10.002","volume":"1863","author":"S Agarwal","year":"2017","unstructured":"Agarwal S, Chattopadhyay M, Mukherjee S, Dasgupta S, Mukhopadhyay S, Bhattacharya S (2017) Fetuin-A downregulates adiponectin through Wnt-PPARgamma pathway in lipid induced inflamed adipocyte. Biochim Biophys Acta Mol Basis Dis 1863(1):174\u2013181. https:\/\/doi.org\/10.1016\/j.bbadis.2016.10.002","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"3","key":"1274_CR27","doi-asserted-by":"publisher","first-page":"297","DOI":"10.14310\/horm.2002.1739","volume":"16","author":"CG Verras","year":"2017","unstructured":"Verras CG, Christou GA, Simos YV, Ayiomamitis GD, Melidonis AJ, Kiortsis DN (2017) Serum fetuin-A levels are associated with serum triglycerides before and 6 months after bariatric surgery. Hormones (Athens) 16(3):297\u2013305. https:\/\/doi.org\/10.14310\/horm.2002.1739","journal-title":"Hormones (Athens)"},{"issue":"10","key":"1274_CR28","doi-asserted-by":"publisher","first-page":"5883","DOI":"10.1016\/S0021-9258(19)39445-1","volume":"265","author":"AJ Cayatte","year":"1990","unstructured":"Cayatte AJ, Kumbla L, Subbiah MT (1990) Marked acceleration of exogenous fatty acid incorporation into cellular triglycerides by fetuin. J Biol Chem 265(10):5883\u20135888","journal-title":"J Biol Chem"},{"key":"1274_CR29","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.cca.2018.05.046","volume":"484","author":"G Ndrepepa","year":"2018","unstructured":"Ndrepepa G (2018) Uric acid and cardiovascular disease. Clin Chim Acta 484:150\u2013163. https:\/\/doi.org\/10.1016\/j.cca.2018.05.046","journal-title":"Clin Chim Acta"},{"issue":"23","key":"1274_CR30","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/j.jacc.2011.08.035","volume":"58","author":"JH Ix","year":"2011","unstructured":"Ix JH, Barrett-Connor E, Wassel CL, Cummins K, Bergstrom J, Daniels LB, Laughlin GA (2011) The associations of fetuin-A with subclinical cardiovascular disease in community-dwelling persons: the Rancho Bernardo Study. J Am Coll Cardiol 58(23):2372\u20132379. https:\/\/doi.org\/10.1016\/j.jacc.2011.08.035","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1274_CR31","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/jch.12313","volume":"16","author":"C Grossman","year":"2014","unstructured":"Grossman C, Shemesh J, Koren-Morag N, Bornstein G, Ben-Zvi I, Grossman E (2014) Serum uric acid is associated with coronary artery calcification. J Clin Hypertens (Greenwich) 16(6):424\u2013428. https:\/\/doi.org\/10.1111\/jch.12313","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"14","key":"1274_CR32","doi-asserted-by":"publisher","first-page":"e6565","DOI":"10.1097\/MD.0000000000006565","volume":"96","author":"H Kim","year":"2017","unstructured":"Kim H, Kim SH, Choi AR, Kim S, Choi HY, Kim HJ, Park HC (2017) Asymptomatic hyperuricemia is independently associated with coronary artery calcification in the absence of overt coronary artery disease: a single-center cross-sectional study. Medicine (Baltimore) 96(14):e6565. https:\/\/doi.org\/10.1097\/MD.0000000000006565","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"1274_CR33","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/joim.12120","volume":"274","author":"H Wang","year":"2013","unstructured":"Wang H, Jacobs DR Jr, Gaffo AL, Gross MD, Goff DC Jr, Carr JJ (2013) Longitudinal association between serum urate and subclinical atherosclerosis: the Coronary Artery Risk Development in Young Adults (CARDIA) study. J Intern Med 274(6):594\u2013609. https:\/\/doi.org\/10.1111\/joim.12120","journal-title":"J Intern Med"},{"issue":"9","key":"1274_CR34","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1210\/jc.2013-1519","volume":"98","author":"KC Sung","year":"2013","unstructured":"Sung KC, Wild SH, Byrne CD (2013) Resolution of fatty liver and risk of incident diabetes. J Clin Endocrinol Metab 98(9):3637\u20133643. https:\/\/doi.org\/10.1210\/jc.2013-1519","journal-title":"J Clin Endocrinol Metab"},{"issue":"39","key":"1274_CR35","doi-asserted-by":"publisher","first-page":"e1517","DOI":"10.1097\/MD.0000000000001517","volume":"94","author":"Y Huang","year":"2015","unstructured":"Huang Y, Huang X, Ding L, Wang P, Peng K, Chen Y, Dai M, Zhang D, Xu M, Bi Y, Wang W (2015) Serum fetuin-A associated with fatty liver index, early indicator of nonalcoholic fatty liver disease: a strobe-compliant article. Medicine (Baltimore) 94(39):e1517. https:\/\/doi.org\/10.1097\/MD.0000000000001517","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"1274_CR36","doi-asserted-by":"publisher","first-page":"E266","DOI":"10.1152\/ajpendo.00262.2017","volume":"314","author":"A Peter","year":"2018","unstructured":"Peter A, Kovarova M, Staiger H, Machann J, Schick F, Konigsrainer A, Konigsrainer I, Schleicher E, Fritsche A, Haring HU, Stefan N (2018) The hepatokines fetuin-A and fetuin-B are upregulated in the state of hepatic steatosis and may differently impact on glucose homeostasis in humans. Am J Physiol Endocrinol Metab 314(3):E266\u2013E273. https:\/\/doi.org\/10.1152\/ajpendo.00262.2017","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"1274_CR37","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3109\/08941939.2016.1149640","volume":"29","author":"C von Loeffelholz","year":"2016","unstructured":"von Loeffelholz C, Horn P, Birkenfeld AL, Claus RA, Metzing BU, Docke S, Jahreis G, Heller R, Hoppe S, Stockmann M, Lock JF, Rieger A, Weickert MO, Settmacher U, Rauchfuss F, Pfeiffer AF, Bauer M, Sponholz C (2016) Fetuin A is a predictor of liver fat in preoperative patients with nonalcoholic fatty liver disease. J Invest Surg 29(5):266\u2013274. https:\/\/doi.org\/10.3109\/08941939.2016.1149640","journal-title":"J Invest Surg"},{"issue":"11","key":"1274_CR38","doi-asserted-by":"publisher","first-page":"4479","DOI":"10.1210\/jc.2008-1505","volume":"93","author":"T Reinehr","year":"2008","unstructured":"Reinehr T, Roth CL (2008) Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. J Clin Endocrinol Metab 93(11):4479\u20134485. https:\/\/doi.org\/10.1210\/jc.2008-1505","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01274-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-020-01274-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01274-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T23:14:57Z","timestamp":1619738097000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-020-01274-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,30]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["1274"],"URL":"https:\/\/doi.org\/10.1007\/s40618-020-01274-w","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,30]]},"assertion":[{"value":"16 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Bioethics Committee of Policlinico Umberto I - Sapienza University of Rome. This study did not involve animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}